放射治疗与介入治疗肝源性脾亢80例疗效对比  

Comparison of radiotherapy and interventional therapy for 80 case of hepatogenic hypersplenism patients

作　　者：张恒[1] 曾茗[2] 

机构地区：[1]陕西省延安市人民医院介入放射室,陕西延安716000 [2]陕西省延安市人民医院CT室,陕西延安716000

出　　处：《临床医学研究与实践》2016年第17期31-32,共2页Clinical Research and Practice

摘　　要：目的分析、比较放射治疗与介入治疗肝源性脾亢的治疗效果。方法选择我院2013年1月至2016年3月收治的80例肝源性脾亢患者,将其随机分为对照组和观察组,各40例。观察组行脾脏外照射治疗,对照组行部分脾脏栓塞术治疗,比较两组患者的治疗效果。结果经治疗,两组甲乙线、甲丙线、丁戊线比较,差异不显著,说明治疗后两组脾脏大小差异无统计学意义(P>0.05);观察组疼痛评分(1.37±0.64)分、发热(1.50±0.74)d,对照组疼痛评分(4.62±3.23)分、发热(4.71±6.58)d,观察组各项指标均优于对照组(P<0.05)。结论放射治疗肝源性脾亢与介入治疗疗效相近,而且可有效降低疼痛和发热反应,值得推广应用。Objective To compare and analyze the clinical efficacy of radiotherapy and interventional therapy for hepato- genic hypersplenism. Methods Eighty cases of patients with hepatogenic hypersplenism were selected from January 2013 to March 2016 in our hospital and were divided randomly into control group and observation group, with 40 cases in each group. The observation group was treated with external irradiation, and the control group was treated with partial spleen em- bolization surgery, and the clinical efficacy were compared between the two groups. Results After the treatment, there was no difference between the AB line, CD line and DE line of the two groups, so there was no statistically significant differ- ence between spleen size of the two groups （P〉0.05）; for the observation group, the pain score was （1.37±0.64） and had a fever was （1.50±0.74） days, for the control group, the pain score was （4.62±3.23） and had a fever was （4.71±6.58） days, the observation group was superior in these indexes （P〈0.05）. Conclusion The clinical effects of radiotherapy and interventional therapy were the same, and they can effectively reduce pain and fever reaction. So, they are worthy for clinical promotion and application.

关 键 词：放射治疗 介入治疗 肝源性脾亢 

分 类 号：R575.2[医药卫生—消化系统]